TRILLIUM THERAPEUTICS INC. [—] Common Shares [—] Series II First Preferred Shares UNDERWRITING AGREEMENTUnderwriting Agreement • March 31st, 2015 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
EXECUTIVE EMPLOYMENT AGREEMENT made as of the 3rd day of June, 2014 Between TRILLIUM THERAPEUTICS INC. (hereinafter called the “Corporation”) - and – DR. NICLAS STIERNHOLM (hereinafter called the “Executive”)Executive Employment Agreement • March 31st, 2015 • Trillium Therapeutics Inc. • Pharmaceutical preparations • Ontario
NOW THEREFORE in consideration of the above, the mutual covenants herein contained and other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto), the parties agree as follows:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2015 • Trillium Therapeutics Inc. • Pharmaceutical preparations • Washington
THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”), effective April 1, 2015 (“Effective Date”), is made between Trillium Therapeutics USA Inc., a Delaware corporation (“Employer” or the “Company”), a subsidiary of Trillium Therapeutics Inc. (the “Parent Company”) and Eric L. Sievers (“Executive”). Executive and the Company are sometimes referred to herein as the “Parties.”
SUBSCRIPTION AGREEMENTAgreement • March 31st, 2015 • Trillium Therapeutics Inc. • Pharmaceutical preparations • Ontario
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR STATE LAWS, AND MAY NOT BE OFFERED FOR SALE IN THE UNITED STATES UNLESS EXEMPT THEREUNDER FROM SUCH REGISTRATION.
